Evidence map›Paper›PMID 37395157›Full record

ArticleJournal of cellular and molecular medicine2023

MALAT1/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA/ROCK pathway.

Ting Wang, Na Li, Lingling Yuan, Mengnan Zhao, Guizhi Li, Yanxia Chen, Hong Zhou

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Noncoding RNA as potential therapeutics to rescue mitochondrial dysfunction in cardiovascular diseases.American journal of physiology. Heart and circulatory physiology · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Plasma Expression andBiomolecules · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The heart of diabetes: unraveling metabolic drivers of cardiomyopathy.Cardiovascular diabetology. Endocrinology reports · 2025
    Review
  15. Review
  16. Article
  17. Biology · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ting WangDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Na LiDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Lingling YuanDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Mengnan ZhaoDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Guizhi LiDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Yanxia ChenDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Hong ZhouDepartment of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.ORCID 0000-0003-3356-9175
Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the underlying mechanism of lncRNA MALAT1 in the pathogenesis of diabetic cardiomyopathy (DCM). DCM models were confirmed in db/db mice. MiRNAs in myocardium were detected by miRNA sequencing. The interactions of miR-185-5p with MALAT1 and RhoA were validated by dual-luciferase reporter assays. Primary neonatal cardiomyocytes were cultured with 5.5 or 30 mmol/L D-glucose (HG) in the presence or absence of MALAT1-shRNA and fasudil, a ROCK inhibitor. MALAT1 and miR-185-5p expression were determined by real-time quantitative PCR. The apoptotic cardiomyocytes were evaluated using flow cytometry and TUNEL staining. SOD activity and MDA contents were measured. The ROCK activity, phosphorylation of Drp1

Indexed as

MicroRNAsRNA, Long Noncoding1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAnimalsApoptosisGlucoseMiceMitochondriaMyocytes, CardiacOxidative Stress1-(5-Isoquinolinesulfonyl)-2-MethylpiperazinefasudilGlucoseMicroRNAsRNA, Long Noncodingcardiomyocyte apoptosisdiabetic cardiomyopathyMALAT1miR-185-5pmitochondrial dynamicsRhoA

Identifiers

PMID37395157
PMCPMC10468660
OpenAlexW4382919493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.